The medical device contract manufacturing market is projected to grow at an annualized rate of 8%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Medical Device Contract Manufacturing Market, 2019-2030,

Submitted by Roots_Analysis on 2020-12-22 06:27.

The medical device contract manufacturing market is estimated to be worth USD 126 Billion in 2030, predicts Roots Analysis

Market-Research

Over the years outsourcing has become a popular trend among medical device developers, allowing such companies to leverage the expertise / substantial production capabilities of CMOs / CDMOs in order to gain cost and time related benefits

Submitted by Roots_Analysis on 2020-12-22 06:26.

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market

Market-Research

To order this detailed 300+ page report, please visit this link

Key Inclusions

A detailed review of

Submitted by Roots_Analysis on 2020-12-21 07:58.

The microbiome therapies pipeline features 260 drugs under evaluation across different phases of development; contract service providers have become an integral part of the supply chain owing to their technical expertise, claims Roots Analysis

Market-Research

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

Submitted by Roots_Analysis on 2020-12-21 07:58.

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Market-Research

Roots Analysis has done a detailed study on Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus ... Read more

Submitted by Roots_Analysis on 2020-12-21 07:57.

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Market-Research

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

Submitted by Roots_Analysis on 2020-12-21 07:56.

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Market-Research

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator

Submitted by Roots_Analysis on 2020-12-21 07:56.

Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market

Market-Research

To order this 350+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-12-21 07:55.

Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world

Market-Research

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.

To order this 350 ... Read more

Submitted by Roots_Analysis on 2020-12-21 07:54.

The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%, till 2030

Market-Research

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-12-21 07:53.

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis

Market-Research

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access

Submitted by Roots_Analysis on 2020-12-21 07:52.

In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules

Market-Research

To order this detailed 290+ page report, please visit this link

Key Inclusions

A detailed review of the overall

Submitted by Roots_Analysis on 2020-12-17 08:36.

Over 90 firms are actively involved in providing in silico services for drug discovery of different types of biologics; of these, over 30 players claim to have the capabilities to offer services for all steps of discovery

Market-Research

Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of

Submitted by Roots_Analysis on 2020-12-17 08:35.

gaurav.chaudhary@rootsanalysis.com In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Market-Research

Roots Analysis has done a detailed study on “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, ... Read more

Submitted by Roots_Analysis on 2020-12-17 08:34.

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Market-Research

Excessive capital requirement and myriad of other complexities associated with the discovery of biologics have prompted drug developers to adopt in silico tools / techniques to expedite the discovery timelines

Roots ... Read more

Submitted by Roots_Analysis on 2020-12-17 08:33.

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Market-Research

research; several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process.

Roots Analysis has announced the addition of ... Read more

Submitted by Roots_Analysis on 2020-12-17 08:33.

Human Microbiome Market: Focus on Therapeutics (including gut-brain axis targeting drugs), Diagnostics and Fecal Microbiota Therapies (FMTs) (3rd Edition), 2019-2030’ report features an extensive study of the current market landscape, offering an informed

Market-Research

To order this detailed 640+ page report, please visit this link

Key Inclusions

A detailed assessment of the

Submitted by Roots_Analysis on 2020-12-17 08:32.

Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the US has emerged as the major hub for microbiome-based research

Market-Research

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic ... Read more

Submitted by Roots_Analysis on 2020-12-17 08:31.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Market-Research

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings. ... Read more

Submitted by Roots_Analysis on 2020-12-17 08:30.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Market-Research

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic

Roots Analysis ... Read more

Submitted by Roots_Analysis on 2020-12-17 08:29.

Pages